News

Results reported in JAMA Ophthalmology show that about 20% of those with diabetic retinopathy have a case that could threaten their vision.

This is the first draft guidance accepting considerations in the industry for designing clinical trials for psychedelic drugs.

The FDA’s approvals this week include: a $3.2 million gene therapy, the first anti-inflammatory drug for cardiovascular disease, a subcutaneous version of Vyvgart for myasthenia gravis and Jardiance and Synjardy for kids with type 2 diabetes. Three rejections by the agency include: a therapy for NASH, for retinal cancer, and for rare fungal infections. In addition, Geron has submitted an NDA for first-in-class therapy for MDS.

The Sandoz's and Boehinger Ingelheim's Humira biosimilars will join Amgen's Amjevita on the formulary of UnitedHealth Group's PBM. Cyltezo may have a marketing edge because of its interchangeability designation.

Recently introduced to the U.S. Senate, the Protect Patient Access to Pharmacies Act (S. 2052) will help to secure Medicare patients’, typically seniors, freedom to receive medications and care from the pharmacy of their choice choice through improvements to the “any willing pharmacy” law.

According to a report conducted by the Centers for Medicare and Medicaid Services (CMS) Office of the Actuary (OACT), researchers project healthcare spending growth to pick back up and reach $7.2 trillion by 2031.

Cannabis may accentuate the effects of HIV on the brain or perhaps may mitigate them because of its anti-inflammatory properties.

Patients with multiple sclerosis (MS) with a plant-rich diet had less symptom burden compared with patients with MS who had an elevated intake of red meat and processed meat.

The FDA has approved a second bispecific antibody to treat patients with diffuse large B-cell lymphoma, as well as Linzess to treat children with constipation. Additionally, an FDA advisory committee recommends approval of Sanofi/AstraZeneca’s RSV vaccine for infants.

If passed, PBMs would not be able to charge fees that are connected to the price of a drug, discounts, or rebates.

Virtual care presents a unique opportunity to achieve the kind of whole-person care that has been discussed in healthcare for decades, if not longer.

Some effects of poor sleep (fatigue, daytime dysfunction) resemble some symptoms of long COVID. As it turns out, infected women who were healthy sleepers before and early in the pandemic were less likely to report long COVID symptoms.

Briana Contreras, an editor with Managed Healthcare Executive, and Peter Wehrwein, managing editor of MHE, got to chatting with the newest editorial advisory board member, Jeffrey Casberg, who is vice president of Clinical Pharmacy at IPD Analytics.

Insurers are using prior authorization and other managed care strategies to control costs associated with the growing number of prescriptions, on- and off-label, for the weight-loss medications.

Embracing Eastern and Western medicine practices is crucial in delivering the best healthcare outcomes.

The new service reflects Uber Health’s initiative to address some of the industry’s greatest insecurities and deliver better experiences across the healthcare ecosystem.

Experts say the successes and failures of alternative payment models (APMs) over the past decade have taught us a few things.

FDA has announced evidence-based changes that will allow more individuals to donate blood without increasing the risk of HIV infection.

The deal, initially tentative, was announced Friday between the administration and those challenging the Affordable Care Act mandate.

In a clinical trial, researchers concluded that direct oral anticoagulants were non-inferior to low-molecular-weight heparin.

Alternative payment models are still coming into focus, but so far, they haven’t lived up to the high expectations.

In efforts to find the effectiveness of metformin, ivermectin and fluvoxamine, researchers of the study observed the medications in adults aged 30 to 85 years who were overweight or obese and had been diagnosed with COVID-19 within the last three days.

The FDA has made three approvals this week: a novel drug for dry eye disease, a new indication for Prevymis to prevent CMV disease in adult kidney transplant recipients, and another prostate cancer indication for Lynparza. The agency has also set target action dates for the first CRISPR gene edited therapy and a supplement indication for Jemperli for earlier treatment of endometrial cancer. Additionally, Janssen submitted sBLA for Carvykti for early treatment of myeloma.

Briana Contreras of MHE spoke with Leah Dewey of Cotiviti in this month’s podcast episode about what she’s seeing as the process of Medicaid Redetermination is well underway.

The company paved the way for prescription digital therapeutics.

Weekly surveillance monitoring, also known as rapid cycle analysis, of more than 245,000 COVID-19 mRNA vaccine doses did not detect a safety signal for any outcome 21 days after vaccination.

The retail giant’s initiative to offer attractive pay in every market they operate reflects in the pay raise of all associates. The average salary for pharmacists is now more than $140,000, not including bonuses and incentives. After investments within the optician and vision department, it’s expected the average wage for opticians to be more than $22.50 an hour.

Coherus will launch Yusimry in July with a list price of $995 per carton (2 x 40 mg/0.8 mL autoinjectors); “the lowest price announced to date of any adalimumab offering in the United States,” the company said.